Protagonist Therapeutics is a clinical-stage biopharmaceutical company that specializes in discovering and developing peptide-based new chemical entities (NCEs) to address significant unmet medical needs in various disease areas. Their proprietary technology platform allows them to transform existing treatment paradigms and improve patient outcomes. With a focus on rare and prevalent diseases where current treatments are limited or inadequate, Protagonist Therapeutics aims to deliver life-changing peptide drug therapies.

They offer a diverse product pipeline that is the result of their innovative research and development efforts. Additionally, the company actively engages in clinical trials, community involvement, and corporate events to stay at the forefront of advancements in their field. Protagonist Therapeutics values collaboration, courage, and inclusivity, as evidenced by their commitment to diversity in their workforce and patient representation in clinical studies.

By embracing the differences of their team members, they strive to create positive outcomes for both their organization and patients. Stay connected with Protagonist Therapeutics to be informed about their latest news and updates in the field of peptide drug therapies